The magnetofection method: Using magnetic force to enhance gene delivery

Biological Chemistry

Volumn 384, Issue 5, 2003, Pages 737-747

  Plank, Christian ^a   Schillinger, Ulrike ^a   Scherer, Franz ^a   Bergemann, Christian ^b   Rémy, Jean Serge ^c   Krötz, Florian ^d   Anton, Martina ^a   Lausier, Jim ^d   Rosenecker, Joseph ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Chemicell GmbH   (Germany)

^c CNRS   (France)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Gene delivery; Gene vectors; Magnetic drug targeting; Magnetic nanoparticles; Magnetofection

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CARDIOVASCULAR AGENT; DNA; LIPOFECTAMINE;

ANIMAL CELL; CELL STRAIN 3T3; CONTROLLED STUDY; DNA VECTOR; ENDOTHELIUM CELL; GENE CONTROL; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAGNETIC STIMULATION; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; ROBOTICS; TISSUE ENGINEERING; UMBILICAL VEIN;

ANIMALS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE TARGETING; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HUMANS; MAGNETICS; TRANSFECTION;

ANIMALIA;

EID: 0037532989     PISSN: 14316730     EISSN: None     Source Type: Journal    
DOI: 10.1515/BC.2003.082     Document Type: Review

References (48)

1. Aiuti, A., Slavin, S., Aker, M., Ficara, F., Deola, S., Mortellaro, A., Morecki, S., Andolfi, G., Tabucchi, A., Carlucci, F. et al. (2002a). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296, 2410-2413.
2. Aiuti, A., Vai, S., Mortellaro, A., Casorati, G., Ficara, F., Andolfi, G., Ferrari, G., Tabucchi, A., Carlucci, F., Ochs, H. D., Notarangelo, L. D. et al. (2002b). Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement. Nature Med. 8, 423-425.
3. Alexiou, C., Arnold, W., Klein, R. J., Parak, F. G., Hulin, P., Bergemann, C., Erhardt, W., Wagenpfeil, S. and Lubbe, A. S. (2000). Locoregional cancer treatment with magnetic drug targeting. Cancer Res. 60, 6641-6648.
4. Beason, R., Dussourd, N. and Deutschlander, M. (1995). Behavioural evidence for the use of magnetic material in magnetoreception by a migratory bird. J. Exp. Biol. 198, 141-146.
5. Bloomfield, V. A. (1996). DNA Condensation. Curr. Opin. Struct. Biol. 6, 334-341.
6. Bunnell, B. A., Muul, L. M., Donahue, R. E., Blaese, R. M. and Morgan, R. A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. USA 92, 7739-7743.
7. Chen, C. A. and Okayama, H. (1988). Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. Biotechniques 6, 632-638.
8. Chuck, A. S., Clarke, M. F. and Palsson, B. O. (1996). Retroviral infection is limited by Brownian motion. Hum. Gene Ther. 7, 1527-1534.
9. Cotten, M., Saltik, M., Kursa, M., Wagner, E., Maass, G. and Birnstiel, M. L. (1994). Psoralen treatment of adenovirus particles eliminates virus replication and transcription while maintaining the endosomolytic activity of the virus capsid. Virology 205, 254-261.
10. Curiel, D. T., Agarwal, S., Wagner, E. and Cotten, M. (1991). Adenovirus enhancement of transferrin polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. USA 88, 8850-8854.
11. Diebel, C. E., Proksch, R., Green, C. R., Neilson, P. and Walker, M. M. (2000). Magnetite defines a vertebrate magnetoreceptor. Nature 406, 299-302.
12. Erbacher, P., Remy, J.-S. and Behr, J.-P. (1999). Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6, 138-145.
13. Fahlvik, A. K., Klaveness, J. and Stark, D. D. (1993). Iron oxides as MR imaging contrast agents. J. Magn. Reson. Imaging 3, 187-194.
14. Fischer, A., Hacein-Bey, S. and Cavazzana-Calvo, M. (2002). Gene therapy of severe combined immunodeficiencies. Nature Rev. Immunol. 2, 615-621.
15. Finsinger, D., Remy, J. S., Erbacher, P., Koch, C. and Plank, C. (2000). Protective copolymers for nonviral gene vectors: synthesis, vector characterization and application in gene delivery. Gene Ther. 7, 1183-1192.
16. Grimm, S. and Kachel, V. (2002). Robotic high-throughput assay for isolating apoptosis-inducing genes. Biotechniques 32, 670-672, 674-677.
17. Gupta, P. K. and Hung, C. T. (1993). Magnetically controlled targeted chemotherapy. In: Microspheres and Regional Cancer Therapy, N. Willmott and J. Daly, eds. (Boca Raton, USA: CRC Press), pp. 71-116.
18. Hiemenz, P. C. (1986). Principles of Colloid and Surface Chemistry (New York, USA: Marcel Dekker, Inc.).
19. Hughes, C., Galea-Lauri, J., Farzaneh, F. and Darling, D. (2001). Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors. Mol. Ther. 3, 623-630.
20. Kass-Eisler, A., Leinwand, L., Gall, J., Bloom, B. and Falck-Pedersen, E. (1996). Circumventing the immune response to adenovirus-mediated gene delivery. Gene Ther. 3, 154-162.
21. Kim, M., Zinn, K., Barnett, B., Sumerel, L., Krasnykh, V., Curiel, D. and Douglas, J. (2002). The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells. Eur. J. Cancer 38, 1917.
22. Kirschvink, J. L., Kobayashi-Kirschvink, A. and Woodford, B. J. (1992). Magnetite biomineralization in the human brain. Proc. Natl. Acad. Sci. USA 89, 7683-7687.
23. Klein, T. M., Arentzen, R., Lewis, P. A. and Fitzpatrick- McElligott, S. (1992). Transformation of microbes, plants and animals by particle bombardment. Biotechnology 10, 286-291.
24. Krötz, F., de Wit, C., Sohn, H.-Y., Zahler, S., Gloe, T., Pohl, U. and Plank, C. (2003). Definition of an important role of p22phox in endothelial superoxide production by magnetofection - a highly efficient tool for oligonucleotide delivery in vitro and in vivo. Mol. Ther., in press.
25. Lewin, M., Carlesso, N., Tung, C. H., Tang, X. W., Cory, D., Scadden, D. T. and Weissleder, R. (2000). Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nature Biotechnol. 18, 410-414.
26. Lohmann, K. J. and Johnsen, S. (2000). The neurobiology of magnetoreception in vertebrate animals. Trends Neurosci. 23, 153-159.
27. Lübbe, A. S., Bergemann, C., Riess, H., Schriever, F., Reichardt, P, Possinger, K., Matthias, M., Dorken, B., Herrmann, F., Gurtler, R. et al. (1996). Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res. 56, 4686-4693.
28. Lübbe, A. S. and Bergemann, C. (1997). Selected preclinical and first clinical experiences with magnetically targeted 4-epidoxorubicin in patients with advanced solid tumors. In: Scientific and Clinical Applications of Magnetic Drug Carriers, U. Häfeli, W. Schütt, J. Teller and M. Zborowski, eds. (New York, London: Plenum Press).
29. Lübbe, A. S. and Bergemann, C. (1998). Magnetically controlled drug targeting. Cancer J. 11, 104-105.
30. Luo, D. and Saltzman, W. M. (2000). Enhancement of transfection by physical concentration of DNA at the cell surface. Nature Biotechnol. 18, 893-895.
31. Mah, C., Fraites, T. J. J., Zolotukhin, I., Song, S., Flotte, T. R., Jon Dobson, Batich, C. and Byrne, S. J. (2002). Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol. Ther. 6, 106-112.
32. Mertl, M. (1999). Magnetic cells: stuff of legend? Science 283, 775.
33. Meyer, K. B., Thompson, M. M., Levy, M. Y., Barron, L. G. and Szoka, F. C., Jr. (1995). Intratracheal gene delivery to the mouse airway: characterization of plasmid DNA expression and pharmacokinetics. Gene Ther. 2, 450-460.
34. Ogris, M., Steinlein, P., Kursa, M., Mechtler, K., Kircheis, R. and Wagner, E. (1998). The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5, 1425-1433.
35. Ogris, M., Brunner, S., Schuller, S., Kircheis, R. and Wagner, E. (1999). PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6, 595-605.
36. Pandori, M. W., Hobson, D. A. and Sano, T. (2002). Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy to localized gene delivery. Virology 299, 204-212.
37. Pilgrimm, H. (1999). Superparamagnetic particles, process for producing the same and their use. US Patent No. 5,916,539; Silica Gel GmbH.
38. Plank, C., Oberhauser, B., Mechtler, K., Koch, C. and Wagner, E. (1994). The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269, 12918-12924.
39. Plank, C., Mechtler, K., Szoka, F. C. and Wagner, E. (1996). Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7, 1437-1446.
40. Scherer, F., Anton, M., Schillinger, U., Henke, J., Bergemann, C., Kruger, A., Gansbacher, B. and Plank, C. (2002). Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102-109.
41. Schwertmann, U. and Cornell, R. M. (1991). Iron Oxides in the Laboratory. Preparation and Characterization (Weinheim, Germany: Wiley/VCH).
42. Somiari, S., Glasspool-Malone, J., Drabick, J. J., Gilbert, R. A., Heller, R., Jaroszeski, M. J. and Malone, R. W. (2000). Theory and in vivo application of electroporative gene delivery. Mol. Ther. 2, 178-187.
43. Terebesi, J., Kwok, K. Y. and Rice, K. G. (1998). Iodinated plasmid DNA as a tool for studying gene delivery. Anal. Biochem. 263, 120-123.
44. Wagner, E., Zatloukal, K., Cotten, M., Kirlappos, H., Mechtler, K., Curiel, D. T. and Birnstiel, M. L. (1992). Coupling of adenovirus to transferrin polylysine DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA 89, 6099-6103.
45. Weissleder, R., Stark, D. D., Engelstad, B. L., Bacon, B. R., Compton, C. C., White, D. L., Jacobs, P. and Lewis, J. (1989). Superparamagnetic iron oxide: pharmacokinetics and toxicity. Am. J. Roentgenol. 152, 167-173.
46. Weissleder, R., Moore, A., Mahmood, U., Bhorade, R., Benveniste, H., Chiocca, E. A. and Basilion, J. P. (2000). In vivo magnetic resonance imaging of transgene expression. Nature Med. 6, 351-355.
47. Wunderbaldinger, P., Bogdanov, A. and Weissleder, R. (2000). New approaches for imaging in gene therapy. Eur. J. Radiol. 34, 156-165.
48. Zborowski, M., Fuh, C. B., Green, R., Sun, L. and Chalmers, J. J. (1995). Analytical magnetapheresis of ferritin-labeled lymphocytes. Anal. Chem. 67, 3702-3712.